drugset / Trial / NCT00489736

Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

NCT00489736

Phase 3 Completed 504 enrolled Sanofi
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to compare the efficacy and safety of dronedarone to that of amiodarone for the treatment of patients with atrial fibrillation.

Timeline

Start
2007-06
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiodarone Small molecule 200 mg Oral
Subject Dronedarone Small molecule 400 mg Oral

Indications